- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 249
Iliev takes the helm at NetScientific
EMV Capital managing director Ilian Iliev has replaced Ian Postlethwaite as CEO of NetScientific on a part-time basis.
May 4, 2020Octopus Energy originates $327m
Origin Energy has agreed to make a strategic investment in energy supplier Octopus Energy for a total of $327m.
May 4, 2020Kurma sets the stage for $175m fund
Life sciences-focused venture firm Kurma Partners has secured Servier Laboratories for a third fund dedicated to early and incubation-stage therapeutics companies.
May 4, 2020Kurma sets the stage for $175m fund
Life sciences-focused venture firm Kurma Partners has secured Pasteur Institute for a third fund dedicated to early and incubation-stage therapeutics companies.
May 4, 2020Corporate venturing deal net: 27 April-1 May 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
May 1, 2020Daily deal net: May 1, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
May 1, 2020Genespire generates $17.6m
San Raffaele-Telethon gene therapy spinout Genespire has picked up series A funding from Sofinnova Partners to target inherited metabolic diseases and primary immunodeficiencies.
May 1, 2020Acacia circles over Woodford assets
Woodford has faced challenges in selling its shareholdings in spinouts including Oxford Nanopore and Immunocore, but has now lined up Acacia as a potential buyer.
May 1, 2020InsideBoard inserts series B funding
Axa Venture Partners and Orange Digital Ventures backed a $27.2m round that will fund product development and international growth for the employee engagement software provider.
May 1, 2020Robocath puts its heart into series C round
Robocath, which is developing robotic-assisted technology for cardiovascular diseases, has collected capital from investors including TUS-Holdings.
Apr 30, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


